China outlined five tasks for strengthening the development of Chinese drug industry in《14th Five-Year Plan for National Health》.
Recently, the General Office of the State Council issued《 “14th Five-Year Plan” for National Health》.
According to China Pharmaceutical News, the plan listed five aspects of tasks to complete to enhance the development of the drug industry.
Firstly, to maintain drug quality and safety, the national drug standard system will be further completed to ensure the evaluation consistency between the quality and efficacy of generic drugs. The quality and efficacy evaluation system in accordance with the characteristics of Chinese medicine will also be established. The plan also emphasized on establishing a life-cycle quality management mechanism for drugs and vaccines to promote the development of traceable information system.
Secondly, to lay a solid foundation for the high-quality development of traditional Chinese medicine (TCM), the live transmission of TCM and the protection and utilization of ancient books and documents will be carried out. The evidence-based ability and technology innovation of TCM will also be reinforced.
Thirdly, to accelerate the innovative development of pharmaceutical industries, the R&D and implementation of novel drugs will be encouraged. The plan also stressed on promoting the R&D and industrialization of drugs for treating clinically urgent serious diseases and the R&D of high-quality generic drugs.
Fourthly, to strengthen the manufacturing of high-end medical devices and healthcare products, the registration and assessment processes for innovative medical devices will be optimized. A group of high-quality artificial intelligence-aided medical equipment will be launched. The standard system for elder care and baby care products will be further completed to support the development and application of the forefront technology and products.
Lastly, the plan also emphasized on promoting rational drug use and strengthening the monitoring of adverse drug reactions.